- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, January 21, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An editorial by the guest editor of the January 2022 Health Information Technology (IT) special issue of The American Journal of Managed Care® (AJMC®) was covered by Becker’s Hospital Review. The piece, “The Health Information Technology Special Issue: Continuing the Progress Toward Digital Transformation,” highlighted the research in the issue and the significant work that remains for provider organizations to integrate digital advancement as a key strategy in addressing some of the most pressing challenges that are transforming the health care landscape.
A piece by EHRIntelligence referenced a study published in the January 2022 Health IT special issue of AJMC®, titled “Approaches for Overcoming Barriers to Cross-Sector Data Sharing.” In the study, authors identified challenges to cross-sector data sharing and the approaches used to overcome these challenges in the Mid-Ohio Farmacy, a partnership to address food insecurity.
An article by Physician’s Weekly cited a study published in a supplement to AJMC®. The study, “The Emerging Role of the Type 2 Inflammatory Cascade in Atopic Diseases,” reviewed the clinical and economic burden of type 2 inflammatory diseases, including asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyps.
Accountable Care Organizations and HPV Vaccine Uptake: A Multilevel Analysis
October 24th 2024The authors evaluated whether adolescents receiving care at accountable care organizations (ACOs) vs non-ACOs were more likely to initiate and complete the human papillomavirus (HPV) vaccination series.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Rozanolixizumab Effective in Patients with MuSK MG, Analysis Shows
October 23rd 2024A new subgroup analysis of patients with muscle-specific tyrosine kinase (MuSK) autoantibody-positive (Ab+) myasthenia gravis (MG) shows rozanolixizumab (Rystiggo) contributes to meaningful symptom improvement.
Read More
